Cortical Tubers Without Neurological Symptoms: An Uncommon Case of Tuberous Sclerosis Complex
Keywords:
Angiofibroma, Cortical tubers, Neurocutaneous syndrome, Shagreen patch, Tuberous sclerosis complex (TSC)Abstract
Tuberous Sclerosis Complex (TSC) is a genetic disorder and rare type of neurocutaneous syndrome characterized by development of benign nodules in various organs of the body including the brain, skin, kidneys, and heart. Epilepsy and mental retardation are common neurological manifestations of this disorder in most cases. However, cases with isolated cutaneous findings and preserved neurological function are rare and have not been well reported in the literature. The purpose of this case report is to highlight the phenotypic variation in the TSC phenotype and to stress the need for increased clinical vigilance in atypical cases.
References
1. Crino PB, Nathanson KL, Henske EP. The Tuberous Sclerosis Complex. N Engl J Med. 2006;355(13):1345–56.
2. Northrup H, Koenig MK, Pearson DA, Au KS. Tuberous Sclerosis Complex. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1999–2023.
3. Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci. 1991; 615:125e127.
4. Northrup H, Krueger DA. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol. 2013; 49:243e254.
5. Ebrahimi-Fakhari D, Mann LL, Poryo M, et al. Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study. Orphanet J Rare Dis. 2018; 13:117.
6. Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet. 2008;372(9639):657–68.
7. Jeong A, Wong M. Tuberous sclerosis complex: Genetics to pathogenesis. Pediatr Neurol. 2016; 58:19–30.
8. Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: Revised clinical diagnostic criteria. J Child Neurol. 1998;13(12):624–8.
9. Kwiatkowski DJ. Tuberous sclerosis: From tubers to mTOR. Ann Hum Genet. 2003;67(Pt 1):87–96.
10. Jansen FE, Braams O, Vincken KL, et al. Overlapping neurological phenotypes in tuberous sclerosis complex: Cerebral and behavioral aspects. Eur J Paediatr Neurol. 2008;12(5):347–56.
11. Altraide DD, George IO, Otike-Odibe B. Tuberous sclerosis: A rare cause of seizure in Nigeria. Nigerian Journal of Medicine. 2010 Sep 29;19(3).
12. Ogunrin AO, Adeyekun AA, Akhigbe AO, Ofovwe CE. Tuberous sclerosis in a young Nigerian male: A case report and review of the literature. Discovery and Innovation. 2005 Dec 1;17(3/4):122.
13. Lagunju IA, Okolo CA, Ebruke BE, et al. Severe neurological involvement in tuberous sclerosis: a report of two cases and a review of the African literature. AJNS,2007;26:2
14. Salido R, Garnacho-Saucedo G, Cuevas-Asencio I, et al. Pulsed dye laser for treatment of facial angiofibromas in tuberous sclerosis: A study of 20 cases. J Am Acad Dermatol. 2012;67(3): e81–3.
15. Kingswood JC, Bolton PF, Crawford P, et al. The clinical profile of tuberous sclerosis complex (TOSCA): Insights into manifestations, diagnosis, and management. Lancet Neurol. 2017;16(5):530–40.
16. Amin S, Lux A, Calder N, et al. Causes of mortality in individuals with tuberous sclerosis complex. Dev Med Child Neurol. 2017;59(6):612–7.
17. Yates JR, Maclean C, Higgins B, et al. The tuberous sclerosis 2000 study: Presentation, initial assessments, and implications for diagnosis and management. Arch Dis Child. 2011;96(11):1020–5.
18. Franz DN, Belousova E, Sparagana S, et al. Efficacy and safety of everolimus in patients with tuberous sclerosis complex-associated tumors. Lancet. 2016;387(10020):1111–9.
19. de Vries PJ, Whittemore VH, Leclezio L, et al. Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND checklist. Pediatr Neurol. 2015;52(1):25–35.
20. Joinson C, O'Callaghan F, Osborne J, et al. Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol Med. 2003;33(2):335–44.
21. Muzykewicz DA, Costello DJ, Halpern EF, et al. Psychiatric comorbidity in older adolescents and adults with tuberous sclerosis complex: A clinic-based survey. Epilepsy Behav. 2007;10(3):504–10.
22. Kwiatkowski DJ. Tuberous sclerosis: From tubers to mTOR. Ann Hum Genet. 2003;67(Pt 1):87–96.
23. Curatolo P, Moavero R, de Vries PJ. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol. 2015;14(7):733–45
24. Omigbodun AO. Strategies for reducing inequalities in healthcare provision for people with genetic disorders in Africa. Afr J Med Med Sci. 2001;30(Suppl):91–4.
